Quinazoline derivatives

Details for Australian Patent Application No. 2009267136 (hide)

Owner Hutchison MediPharma Enterprises Limited

Inventors Su, Wei-Guo; Ren, Yongxin; Yan, Xiaoquiang; Zhang, Weihan; Yang, Haibin; Cui, Yumin

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009267136

PCT Pub. Number WO2010/002845

Priority 12/164,610 30.06.08 US

Filing date 30 June 2009

Wipo publication date 7 January 2010

International Classifications

C07D 239/72 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 239/95 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2010/002845 Priority application(s): WO2010/002845

18 August 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Su, Wei-Guo; Ren, Yongxin; Yan, Xiaoqiang; Zhang, Weihan; Yang, Haibin and Cui, Yumin

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009267137-Differentiation of pluripotent stem cells

2009267135-Method, apparatus, system, and article of manufacture for reliable lowbandwidth information delivery across mixed-mode unicast and multicast networks